What is Kylene Polhamus's NPI number?

Kylene Polhamus's National Provider Identifier (NPI) is 1427464890, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Kylene Polhamus's specialty?

Kylene Polhamus is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).

Where is Kylene Polhamus located?

Kylene Polhamus's practice location on file with NPPES is 1320 City Center Dr Ste 150, Carmel, IN 46032-3104.

What is Kylene Polhamus's phone number?

The practice phone number listed in the NPPES registry for Kylene Polhamus is (574) 293-3545.

Does Kylene Polhamus accept Medicare?

Kylene Polhamus is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Kylene Polhamus's NPI active?

Yes — Kylene Polhamus's NPI (1427464890) is active in the NPPES registry as of the last update on 2024-12-27.

IndividualActiveAccepts Medicare

Kylene Polhamus, O.D.

NPI 1427464890 · Optometrist · Carmel, IN

Kylene Polhamus, O.D. is a Optometrist provider in Carmel, IN (NPI 1427464890).

Provider details

NPI number: 1427464890
Entity type: Individual
Primary specialty: OptometristEye and Vision Services Providers
Credential: O.D.
Sex: Female
Sole proprietor: Yes
License: 18003841A (IN)

Practice location

1320 City Center Dr Ste 150

Carmel, IN 46032-3104

Phone: (574) 293-3545

Street-level locationGet directions

Mailing address

1320 City Center Dr Ste 150

Carmel, IN 46032-3104

Specialties & taxonomies

OptometristPrimary152W00000XLicense 18003841A (IN)
Eye and Vision Services Providers

Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(71/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
12 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
770 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	308	$86
Established Patient Complete Exam of Visual System92014	194	$118
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	160	$122
Imaging of Retina92134	32	$38
New Patient Complete Exam of Visual System92004	26	$141
Imaging of Optic Nerve92133	20	$34

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Lifitegrastbrand: Xiidra	105	62
Perfluorohexyloctane/Pfbrand: Miebo	84	22
Prednisolone Acetate	62	47
Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth	60	49
Varenicline Tartratebrand: Tyrvaya	57	24
Doxycycline Hyclate	46	40
Cyclosporinebrand: Cequa	45

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,001 across 70 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2014-07-07
Last updated: 2024-12-27
Certified: 2024-12-27

Frequently asked questions

What is Kylene Polhamus's NPI number?: Kylene Polhamus's National Provider Identifier (NPI) is 1427464890, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Kylene Polhamus's specialty?: Kylene Polhamus is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
Where is Kylene Polhamus located?: Kylene Polhamus's practice location on file with NPPES is 1320 City Center Dr Ste 150, Carmel, IN 46032-3104.
What is Kylene Polhamus's phone number?: The practice phone number listed in the NPPES registry for Kylene Polhamus is (574) 293-3545.
Does Kylene Polhamus accept Medicare?: Kylene Polhamus is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Kylene Polhamus's NPI active?: Yes — Kylene Polhamus's NPI (1427464890) is active in the NPPES registry as of the last update on 2024-12-27.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	308	$86
Established Patient Complete Exam of Visual System92014	194	$118
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	160	$122
Imaging of Retina92134	32	$38
New Patient Complete Exam of Visual System92004	26	$141
Imaging of Optic Nerve92133	20	$34

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Lifitegrastbrand: Xiidra	105	62
Perfluorohexyloctane/Pfbrand: Miebo	84	22
Prednisolone Acetate	62	47
Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth	60	49
Varenicline Tartratebrand: Tyrvaya	57	24
Doxycycline Hyclate	46	40
Cyclosporinebrand: Cequa	45

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,001 across 70 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments